DexCom ROE - Return on Equity 2010-2025 | DXCM

DexCom return on equity for the quarter ending March 31, 2025 was 24.41.

  • DexCom average return on equity for 2024 was 29.14, a 58.63% decline from 2023.
  • DexCom average return on equity for 2023 was 18.37, a 44.3% increase from 2022.
  • DexCom average return on equity for 2022 was 12.73, a 54.84% increase from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

DexCom ROE - Return on Equity 2010-2025 | DXCM

  • DexCom average return on equity for 2024 was 29.14, a 58.63% decline from 2023.
  • DexCom average return on equity for 2023 was 18.37, a 44.3% increase from 2022.
  • DexCom average return on equity for 2022 was 12.73, a 54.84% increase from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.